ProgressImage ProgressImage
Supriya Lifescience Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 543434 border-img ISIN Demat INE07RO01027 border-img Book Value 134.41 border-img NSE Symbol SUPRIYA border-img Div & Yield % 0.12 border-img Market Cap ( Cr.) 6496.97 border-img P/E 35.01 border-img EPS 23.06 border-img Face Value 2
ParticularsMar 2025
()
Mar 2024
()
Mar 2023
()
Mar 2022
()
Mar 2021
()
Mar 2020
()
INCOME :       
Sales Turnover 781.92646.93516.47588.52430.97311.64
Excise Duty 85.4476.5955.5358.4739.760.00
Net Sales 696.48570.34460.94530.05391.21311.64
Other Income 9.8210.649.497.585.0111.07
Stock Adjustments 21.26-30.316.513.0312.4413.90
Total Income 727.56550.67476.94540.66408.66336.61
EXPENDITURE :       
Raw Materials 232.44191.43187.32198.83140.57152.38
Power & Fuel Cost 24.8021.3720.9514.079.248.97
Employee Cost 80.5267.6455.5849.0832.7618.88
Other Manufacturing Expenses 51.8135.6828.8718.4413.158.27
Selling & Administrative Expenses 54.6538.1037.3233.8331.8830.10
Miscellaneous Expenses 12.619.808.514.842.928.56
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure 456.83364.01338.55319.09230.51227.15
Operating Profit 270.73186.65138.38221.56178.15109.45
Interest 1.815.153.084.204.086.85
Gross Profit 268.92181.50135.30217.36174.07102.60
Depreciation 20.4415.8111.8210.126.766.41
Profit Before Tax 248.48165.69123.48207.24167.3196.19
Tax 56.6637.1030.6852.1943.0225.07
Fringe Benefit tax 0.000.000.000.000.000.00
Deferred Tax 3.879.482.953.250.69-2.23
Reported Net Profit 187.96119.1189.86151.81123.5973.35
Extraordinary Items -0.010.00-0.080.000.000.00
Adjusted Net Profit 187.97119.1189.94151.81123.5973.35
Adjustment below Net Profit 0.000.000.000.000.00-3.36
P & L Balance brought forward 600.45486.16401.13253.72134.0879.08
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 6.444.834.834.393.9614.64
P & L Balance carried down 781.97600.45486.16401.13253.72134.43
Dividend 0.000.000.000.000.0014.64
Preference Dividend 0.000.000.000.000.000.00
Equity Dividend % 50.0040.0030.0030.0027.00100.00
Dividend Per Share(Rs) 1.000.800.600.600.5410.00
Earnings Per Share-Unit Curr 23.3514.8011.1618.8616.8950.11
Earnings Per Share(Adj)-Unit Curr 23.3514.8011.1618.8616.8950.11
Book Value-Unit Curr 123.84101.3186.9176.5036.70101.84
Book Value(Adj)-Unit Curr 123.84101.3186.9176.5036.70101.84
`

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.   Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day...... issued in the interest of investors.    KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.      No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment.No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account   |    Website Accessibility Statement

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.

x
x
×
Let's Chat
imsl-img
close
refresh